Navigation Links
Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product
Date:9/25/2008

Recognizes Scientific Accomplishment in Complement Inhibition and Impact of Soliris on Patients Living with PNH

CHESHIRE, Conn., Sept. 25 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) has received a Prix Galien USA 2008 Award for Best Biotechnology Product for Soliris(R) (eculizumab). The Award recognizes the scientific innovation represented by the complement-inhibition technology of Soliris, and the impact the drug is having on the lives of patients with paroxysmal nocturnal hemolglobinuria (PNH), a rare, debilitating and life-threatening blood disorder.

Soliris is a first-in-class complement inhibitor that selectively blocks the formation of terminal complement, a component of the normal immune system. Patients with PNH lack naturally occurring proteins that ordinarily prevent terminal complement from causing the red blood cell destruction (hemolysis) that is central to the serious morbidities and mortality associated with PNH.

"We are living in the midst of a biological revolution and the breakthrough agents honored by the Prix Galien USA illustrate the substantial research and development necessary to bring the fruits of that revolution in molecular medicine to the clinic," said Gerald Weissmann, M.D., Prix Galien USA committee chair, New York University professor emeritus and editor-in-chief of The FASEB Journal.

"We deeply appreciate this honor, which recognizes more than 15 years of dedicated complement-based research. The Prix Galien award is especially gratifying for the scientists, physicians, patients and advocates involved in the discovery and development of Soliris," said Leonard Bell, M.D., Chief Executive Officer of Alexion. "We are committed to making sure that every pa
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
2. Kuvan Receives Positive Opinion From CHMP for European Approval
3. Corgenix Receives Third U.S. Patent on AtherOx(R) Technology
4. Sustainable Oils Receives Regulatory Approval for Feeding Camelina Meal in Livestock Diets
5. U.S. Genomics Inc. Receives $4.5 Million Investment from BD
6. AdvanDx Receives FDA 510(k) Clearance for Yeast Traffic Light PNA FISH(TM)
7. PLC Systems Receives Delisting Notice From American Stock Exchange
8. Nephros Receives Non-Compliance Notification from AMEX
9. China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII
10. Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules
11. Intact Medical Corporations Intact(R) Excise XL Receives 510(K) Marketing Clearance from the FDA

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... BOCA RATON, Fla., Nov. 25 For man... for BodyLogicMD. The nation,s largest and fastes...g exclusively in medically supervised bioidentica... in its network since November 2008 - from 21 t...physician-owned centers, including one in Puerto R...
(Date:11/25/2009)...25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( SVA...nnounced today that it executed,a joint venture (J...,Technology Co., Ltd. (Sinovac Dalian). The JV wil...an-use vaccines. Sinovac will contribute its exper...ing world-class vaccines; the,other party will bri...
(Date:11/25/2009)...wswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasd...harm.D., president and chief executive officer, wi... Care Conference. , ,Presentation details are as ...nference,Date: Tuesday, December 1, 2009,Time...ork Palace Hotel, New York, NY,Webcast: <a href...
(Date:11/24/2009)...ewswire-FirstCall/ -- IES (Nasdaq: IESC ), a lead...ions systems and services for the commercial, indu...at its commercial business group has been awarded ... electrical systems for the Level 4 bio-safety lab...ical Research Institute of Infectious Diseases (US...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
... 7 BioSpace, the leading biotech job,board and li...biotechnology,and pharmaceutical job seekers to th...sda, MD. The BioSpace Career Fair attracted a ste...utical, medical device, and diagnostics career,can...ster and Mid-Atlantic,region. The event offered a ...
..., Calif., Nov. 6 Renovis,Inc. (Nasdaq: RNVS ), a...y,and development of drugs for major medical needs...eases, today announced financial results,for the t...r the third quarter and the nine months ended Sept...espectively, compared to $2.2,million and $8.3 mil...
...ess of Siemens Medical Solutions Diagnostics, ERL...ompleted the acquisition of Dade Behring Holdings,... existing business of Siemens,Medical Solutions Di...and,rapidly growing field of in vitro diagnostics,...comprehensive healthcare solutions, portfolio, whi...
Other Biology Technology:BioSpace Career Fair in Bethesda, Maryland Draws Hundreds of Industry Professionals 2Renovis Reports Third Quarter 2007 Financial Results 2Renovis Reports Third Quarter 2007 Financial Results 3Renovis Reports Third Quarter 2007 Financial Results 4Renovis Reports Third Quarter 2007 Financial Results 5Renovis Reports Third Quarter 2007 Financial Results 6Renovis Reports Third Quarter 2007 Financial Results 7Renovis Reports Third Quarter 2007 Financial Results 8Siemens Completes Acquisition of Dade Behring 2Siemens Completes Acquisition of Dade Behring 3
(Date:11/24/2009)...e atomic-level action of a remarkable class of rin...archers with the Lawrence Berkeley National Labora...in crystallography beamline at the Advanced Light ...les in gene expression and replication, and are vi...ll as infectious agents, such as the human papillo...
(Date:11/24/2009)...mbridge, Md. (November 24, 2009) New research on ...river ecosystems reveals predictable temporal patt...ommunities as markers for monitoring climate chang...week in the Proceedings of the National Academy o...mmunities in the six rivers shifted synchronously ...
(Date:11/23/2009)...TORONTO, November 23, 2009 - The time of day matte... to a new paper produced by a research team led by... Scarborough,s vice-principal for research and col...ogy at the St. George campus. , Capitalizing o...poplar tree, the research team examined how poplar...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Time of day matters to thirsty trees, U of T researcher discovers 2ERT Achieves Cardiac Safety Milestone after Completing 150th TET Trial 56144 1ERT Achieves Cardiac Safety Milestone after Completing 150th TET Trial 56144 2ERT Achieves Cardiac Safety Milestone after Completing 150th TET Trial 56144 3Coverall Honored as Finalist in Six Categories for 2009 Stevie Awards 56139 1Coverall Honored as Finalist in Six Categories for 2009 Stevie Awards 56139 2Coverall Honored as Finalist in Six Categories for 2009 Stevie Awards 56139 3Oramed Pharmaceuticals to Present at Rodman 26 Renshaw 11th Annual Healthcare Conference 13832 1Oramed Pharmaceuticals to Present at Rodman 26 Renshaw 11th Annual Healthcare Conference 13832 2
...ns could help control weight, lower fat and choles...s, reports Lisa Richards in Chemistry & Indust...eady been hailed for its cholesterol lowering capa...od manufacturer Birds Eye has added the beans to i...s shown that black soya may be even more potent in...
...t athletic performance can lead to diabetes, repor... Journal of Sports Medicine. , The study reports t... who required emergency care for chest pain. , ...d also experienced excessive urination, thirst, an...roids for 15 years and artificial growth hormone f...
...y pick up lung cancer with "moderate accuracy" eve...ahead of print in Thorax. , It could revolutionise...ives, say the authors. , The test comprises a c...in the unique chemical signature of the breath of ... lung cancer cells cause changes in the production...
Other Biology News:
DNase I, RNase-free; special quality for molecular biology from Roche Applied Science
RQ1 RNase-Free DNase from Promega
... DNA Polymerase I catalyzes the template-directed ... 5?3 direction. DNA Polymerase I possesses a 3?5 e...ich lowers the error rate during DNA replication, ...h enables the enzyme to replace nucleotides in the...
RNase-Free Dnase from BD Biosciences Pharmingen
Biology Products: